circadin 2mg tabletas de liberacion prolongada
rad neurim pharmaceuticals eec limited - melatonina - melatonina....2.0 mg
melotin
arrotex pharmaceuticals (nz) limited - melatonin 2mg; - modified release tablet - 2 mg - active: melatonin 2mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid copolymer purified talc - indicated as a monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients aged 55 years and over.
slenyto
rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psycholeptics - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.
melatonin bluefish 2 mg retardtabletten
circadin
rad data australia pty ltd - melatonin -
circadin
pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg; ; - modified release tablet - 2 mg - active: melatonin 2mg excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
vigisom
pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg; ; - modified release tablet - 2 mg - active: melatonin 2mg excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
melotin mr melatonin 2 mg modified release tablet blister pack
generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: magnesium stearate; purified talc; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; lactose monohydrate; ammonio methacrylate copolymer - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
melatonin arx melatonin 2 mg modified release tablet blister pack
apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
melotin melatonin 2 mg modified release tablet blister pack
generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.